These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7652503)

  • 1. Carbapenem treatment of meningitis.
    Klugman KP; Dagan R
    Scand J Infect Dis Suppl; 1995; 96():45-8. PubMed ID: 7652503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meningitis caused by Pseudomonas aeruginosa. Treatment with meropenem].
    Barberán J; García MC; Campos A; Khorrami S
    Enferm Infecc Microbiol Clin; 1998 May; 16(5):249. PubMed ID: 9666592
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group.
    Klugman KP; Dagan R
    Antimicrob Agents Chemother; 1995 May; 39(5):1140-6. PubMed ID: 7625802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meropenem, a new carbapenem antibiotic.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(4):644-69. PubMed ID: 9250544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group.
    Schmutzhard E; Williams KJ; Vukmirovits G; Chmelik V; Pfausler B; Featherstone A
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():85-97. PubMed ID: 8543502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory data which differentiate meropenem and imipenem.
    Edwards JR; Turner PJ
    Scand J Infect Dis Suppl; 1995; 96():5-10. PubMed ID: 7652504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenems: monotherapy in intra-abdominal sepsis.
    Wilson SE
    Scand J Infect Dis Suppl; 1995; 96():28-33. PubMed ID: 7652500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenems: a potent class of antibiotics.
    Nicolau DP
    Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenems in serious infections: a risk-benefit assessment.
    Norrby SR
    Drug Saf; 2000 Mar; 22(3):191-4. PubMed ID: 10738843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
    Kuo BI; Fung CP; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the efficacy and tolerability of meropenem in the treatment of serious bacterial infections.
    Mohr JF
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S41-51. PubMed ID: 18713049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies and new developments in the management of bacterial meningitis.
    Miranda J; Tunkel AR
    Infect Dis Clin North Am; 2009 Dec; 23(4):925-43, viii-ix. PubMed ID: 19909891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term outcome of neonatal Citrobacter koseri (diversus) meningitis treated with imipenem/meropenem and surgical drainage.
    Straussberg R; Harel L; Amir J
    Infection; 2001 Oct; 29(5):280-2. PubMed ID: 11688908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group.
    Odio CM; Puig JR; Feris JM; Khan WN; Rodriguez WJ; McCracken GH; Bradley JS
    Pediatr Infect Dis J; 1999 Jul; 18(7):581-90. PubMed ID: 10440432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenems in paediatrics.
    Blumer JL
    Scand J Infect Dis Suppl; 1995; 96():38-44. PubMed ID: 7652502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
    Morinaga Y; Yanagihara K; Nakamura S; Yamamoto K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
    J Antimicrob Chemother; 2008 Dec; 62(6):1326-31. PubMed ID: 18835805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment.
    Kanegaye JT; Soliemanzadeh P; Bradley JS
    Pediatrics; 2001 Nov; 108(5):1169-74. PubMed ID: 11694698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of meropenem in experimental meningitis.
    Nairn K; Shepherd GL; Edwards JR
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():73-84. PubMed ID: 8543501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.